United States · 
Who invested in Viracta Therapeutics?
Viracta Therapeutics's investors include Forward, Latterell and NantKwest/ Wicklow.
United States · Series B startup
Who invested in Viracta Therapeutics
Funding summaryUpdated 26 Oct 2026
$18Mraised across 1 round since 2017, from 1 source
- Latest round
- Series B, $18MApr 2017
- Investors
- 3
The rounds
- Apr 2017
Founders and team
From the SEC filings it signed: 2 on the team.
- Daniel ChevallardExecutive Officeri
- Ivor RoystonExecutive Officer, Directori
On the board, as filediGur RoshwalbMichael HuangRichard GhalieRoger PomerantzSamuel Murphy
Everyone who backed them
Latterellno record of our own yet1round
NantKwest/ Wicklowno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Viracta Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Viracta Therapeutics
How much has Viracta Therapeutics raised?
Viracta Therapeutics has raised $18M across 1 round since 2017.
When did Viracta Therapeutics last raise?
Viracta Therapeutics's most recent round was a Series B of $18M in Apr 2017.
What was Viracta Therapeutics's biggest round?
Its most recent round, $18M in Apr 2017, is also its largest on record.
Who backed Viracta Therapeutics first?
Viracta Therapeutics's first round on record, in Apr 2017, was backed by Forward, Latterell and NantKwest/ Wicklow.
What stage is Viracta Therapeutics at?
Viracta Therapeutics's latest named round is a Series B, in Apr 2017.
Where is Viracta Therapeutics based?
Viracta Therapeutics is based in the United States.
Companies like Viracta Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.